Moderna (MRNA)
(Delayed Data from NSDQ)
$122.50 USD
+1.36 (1.12%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $122.44 -0.06 (-0.05%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
MRNA 122.50 +1.36(1.12%)
Will MRNA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MRNA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRNA
Top Research Reports for Amazon.com, Prologis & Infosys
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
MRNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings
Moderna (MRNA) Stock Moves -0.93%: What You Should Know
Other News for MRNA
Check Out What Whales Are Doing With MRNA
Top Research Reports For Amazon.com, Prologis & Infosys
Here are Big Pharma’s leading blockbuster makers
3 Flying Car Stocks That Could Be Multibaggers in the Making: July Edition
Decoding Moderna's Options Activity: What's the Big Picture?